Meridian Bioscience Inc.
Cincinnati, OH
- UEI
- HWJ5BXUMNGK5
- CAGE
- 8X084
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Meridian Life Science Inc. · Memphis, TN RR86UP3TSPF6
- KDQ1DSLJ1YG3
- SURKL2N5KG68
- Billerica, MA WKK8N9E7BFX9
- LAMSVKQHFW15
-
- SAM.gov registration date
- Physical address
- 3471 River Hills Dr, Cincinnati, OH 45244, USA
- Website
- meridianbioscience.com
- Founded
- 1977
- Employees
- 251-1K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $343,423 |
| FY2025 | -$1,473,223 |
| FY2024 | $266,634 |
| FY2023 | $190,694 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $211,590 | |
| 2 | Department of Veterans Affairs | $112,085 | |
| 3 | Defense Health Agency | $19,748 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Roche Diagnostics Corporation | Indianapolis, IN | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Luminex Corp | Austin, TX | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Abbott Molecular Inc. | Des Plaines, IL | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Abbott Nutrition | Lake Bluff, IL | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Biofire Diagnostics LLC | Salt Lake City, UT | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Meridian Bioscience Inc., a foreign-owned Cincinnati-based manufacturer of in vitro diagnostic test kits, reagents, and automated analyzers, operates as a prime federal contractor supplying diagnostic equipment and laboratory supplies to 34 federal customer agencies across the Department of Veterans Affairs, Department of Defense health components, Indian Health Service, and the Centers for Disease Control and Prevention. The vendor competes in full-and-open federal procurement with no set-aside designations across its prime footprint, and operates five named subsidiaries—Bioline USA Inc., Magellan Diagnostics Inc., OEM Concepts Incorporated, Biodesign International Inc., and Meridian Life Science Inc.—that extend capability depth in diagnostics manufacturing and international distribution.
Meridian's concrete capability portfolio centers on point-of-care and laboratory diagnostic equipment systems, consumable reagents, and extended warranty support. Representative recent prime work includes a $150,740.50 firm fixed-price purchase order from the Defense Health Agency awarded October 1, 2026, for H. pylori and C. difficile testing reagents and analyzer systems serving Fort Hood, Texas military medical facilities; a $310,583 definitive contract from Veterans Integrated Service Network 22 awarded January 10, 2025, for urea breath ID kits and BreathID Smart equipment technical support; a $931,985 five-year Blanket Purchase Agreement from the Indian Health Service awarded June 13, 2024, for BREATH ID Smart System equipment, associated supplies, and extended warranty services at the Phoenix Indian Medical Center; and a $250,000 single-award Blanket Purchase Agreement from Veterans Integrated Service Network 22 awarded August 10, 2026, for Curian H. pylori stool antigen analyzers and accessories at the VA San Diego Healthcare System. The vendor manufactures sole-source FDA-approved diagnostic instruments (Curian, BREATH ID Smart, I-STAT) that anchor award justifications under simplified acquisition and commercial item procedures.
Customer concentration remains fragmented across DoD medical and VA health networks. The top five customer agencies by award count account for only 5 percent of the vendor's 1,456 total awards, but the top five by potential value cover 31 percent of combined dollars: the Department of the Army Medical Command leads with 19 awards and $2 million combined potential value, followed by the Department of the Air Force Materiel Command (9 awards, $2 million), the Indian Health Service (10 awards, $1.5 million), Veterans Integrated Service Network 22 (8 awards, $899 thousand), and the Defense Health Agency (4 awards, $717 thousand). The disconnect between award count and dollar concentration reflects Meridian's model of small-to-mid-range purchase orders and BPA calls distributed across dozens of hospital and clinic locations within larger health systems, with occasional larger equipment and warranty contracts anchoring dollar value.
Activity remains steady but modest in the recent window—1 award in 2021, 5 in 2023, 5 in 2024, 3 in 2025, and 5 in 2026 through early October. Combined potential value across all 1,456 awards sits at $23 million, with $16.4 million obligated (71 percent execution rate). The top parent vehicles are predominantly single-award BPAs with the VA and Indian Health Service: the Air Force Blanket Purchase Agreement FA860114A0001 carries 5 task orders valued at $421 thousand; FA860117A0021 carries 4 task orders at $384 thousand; and the Indian Health Service BPA 75H71224A00011 carries 3 task orders at $544 thousand. Only 4 awards face ultimate completion within the next twenty-four months (combined potential value $291 thousand), indicating minimal recompete cliff risk in the near term.
Award taxonomy reflects pure diagnostic equipment and reagent supply positioning. Primary NAICS coding clusters on In-Vitro Diagnostic Substance Manufacturing (88 awards) and Analytical Laboratory Instrument Manufacturing (17 awards); top PSC codes run In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (605 awards), Laboratory Equipment and Supplies (578 awards), and Medical and Surgical Instruments, Equipment and Supplies (142 awards). The vendor holds no subcontracting footprint in federal work—all 1,456 awards are prime awards with zero sub-awards in the source data, positioning Meridian as an equipment and consumable direct-sale vendor rather than a systems integrator or service prime.
Quick answers
Is Meridian Bioscience Inc. registered in SAM.gov?
Yes. Meridian Bioscience Inc.'s SAM.gov registration is active through January 8, 2027.
What is Meridian Bioscience Inc.'s most recent federal award?
Meridian Bioscience Inc.'s most recent federal contract award is H. Pylori and c. Difficile testing reagents and analyzer (W81K0026PA157), from Medical Command (Army), on October 1, 2026.
On GovTribe
See Meridian Bioscience Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors